The Latest in Psoriatic Arthritis ICYMI

Obesity may attenuate anti-TNF response in psoriatic arthritis

June 25, 2016

Psoriatic Arthritis

TB still a risk in psoriasis patients taking TNF blockers

June 15, 2016

Psoriatic Arthritis

TNF blocker safety may differ in RA and psoriasis patients

June 14, 2016

Psoriatic Arthritis

Full resolution of psoriasis in half of ixekizumab patients

June 14, 2016

Psoriatic Arthritis

Doctors ask Congress to stop Part B drug payment test

May 17, 2016

Psoriatic Arthritis

Serious infections are increasing among psoriasis inpatients

May 16, 2016

Psoriatic Arthritis

PIANO study provides insight on safety of biologics in pregnancy

May 11, 2016

Psoriatic Arthritis

Brodalumab effective for rare, severe types of psoriasis

May 6, 2016

Psoriatic Arthritis

Remicade to infliximab biosimilar switches fare well in real-life practice

May 3, 2016

Psoriatic Arthritis

Effective psoriasis therapy may reduce coronary plaque burden

April 28, 2016

Psoriatic Arthritis

After Inflectra’s approval, challenges remain for biosimilars

April 26, 2016

Psoriatic Arthritis

Psoriasis tied to abdominal aortic aneurysm in nationwide study

April 14, 2016

Psoriatic Arthritis

Clazakizumab safe, effective for PsA treatment

April 8, 2016

Psoriatic Arthritis

Inflectra becomes first FDA-approved biosimilar for inflammatory diseases

April 5, 2016

Psoriatic Arthritis

Severe psoriasis, kidney disease linked

April 2, 2016

Psoriatic Arthritis